PMID: 6171156Dec 1, 1981Paper

Long-term antiarrhythmic therapy with acetylprocainamide

The American Journal of Cardiology
J KlugerD E Drayer

Abstract

Nineteen patients whose arrhythmias were initially suppressed with acetylprocainamide underwent long-term treatment with this drug. Eleven patients were still taking the drug at the end of 12 months. Drug withdrawal with substitution of a placebo caused an increase in ventricular premature beats. Thus, suppression of ventricular premature beats persisted for 1 year. The eight withdrawals from the study were due to death during the year (n = 6) or recurrence of arrhythmias. The deaths occurred in patients who were in New York Heart Association functional class II (one patient), III (three patients) and IV (two patients). Ventricular performance, assessed from systolic time intervals, improved with drug therapy and declined during drug withdrawal. Symptomatic effects were common, with seven patients requiring a reduction in dosage or discontinuation of therapy. Three patients treated for 3 years continued to show drug suppression of ventricular premature beats compared with the level during placebo substitution. Small amounts of procainamide were present in all patients because of in vivo deacetylation of acetylprocainamide. Many patients with good initial responses to this drug had recurrent arrhythmias during long-term therapy....Continue Reading

References

May 26, 1977·The American Journal of Cardiology·A F FasolaD P Zipes
Dec 20, 1979·The New England Journal of Medicine·R LahitaM M Reidenberg
Oct 26, 1979·European Journal of Pharmacology·R D Reynolds, B L Kamath
May 1, 1979·Annals of Internal Medicine·G P StecJ Askenazi
Jul 1, 1979·Proceedings of the Society for Experimental Biology and Medicine·J J LertoraL I Goldberg
May 1, 1978·Circulation·R A WinkleD C Harrison
Jul 1, 1971·Circulation·B Lown, M Wolf
Mar 1, 1974·Circulation·J R BurgJ Metcalfe
Jun 1, 1974·Proceedings of the Society for Experimental Biology and Medicine·D E DrayerR W Sevy
Dec 1, 1981·Proceedings of the Society for Experimental Biology and Medicine·J KlugerM M Reidenberg
Sep 1, 1980·The American Journal of Cardiology·A M GreenspanM E Josephson
Mar 13, 1980·The New England Journal of Medicine·P J PodridB Lown
May 1, 1980·Arthritis and Rheumatism·M M ReidenbergW C Robbins
Dec 1, 1980·Circulation·M SamiR F DeBusk

❮ Previous
Next ❯

Citations

Dec 1, 1982·The American Journal of Cardiology·B OlshanskyS Hunt
Jan 27, 1992·Annals of the New York Academy of Sciences·R Campbell, A Loaiza
Dec 1, 1983·The American Journal of Medicine·M M Reidenberg
Jul 1, 1984·The American Journal of Cardiology·T MeinertzT Pop
Aug 26, 1993·The American Journal of Cardiology·D M Roden
Jan 1, 1984·Annals of the New York Academy of Sciences·E G Giardina
Apr 1, 1983·Drug Intelligence & Clinical Pharmacy·M B BottorffR L Batenhorst

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.